The Council of the European Union has published a second set of corrections as part of a corrigendum for the EU’s Medical Devices Regulation (MDR), this time giving manufacturers of certain Class I devices an additional four years to comply.
News & Trends
Procurar
Recentes
- MDCG 2019-6 Rev5 Questions and answers: Requirements relating to notified bodies Revision 5 – February 2025
- Formação, Alteração e Revisão Anual de PREÇOS de MEDICAMENTOS: “Formação muito enriquecedora sobre o tema”
- EU Cosmetics Deadlines – New Rules Effective 01 February 2025
- Biomanufacturing: Europe’s Industrial Future
- Plataforma europeia de monitorização da escassez de medicamentos entrou em funcionamento
- FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions
- IMDRF Characterization Considerations for Medical Device Software and Software-Specific Risk
- Commission publishes the Guidelines on prohibited artificial intelligence (AI) practices, as defined by the AI Act.